{"title":"丙型肝炎病毒感染:一个不断发展的医学领域","authors":"W. Abuelhassan","doi":"10.1080/10158782.2012.11441481","DOIUrl":null,"url":null,"abstract":"Hepatitis C infection is a leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma. It is also an important indication for liver transplantation in the USA and Europe, yet it is potentially curable. It is estimated that 3% of the world population (170 million people) are infected with hepatitis C. The highest prevalence is in North Africa and the Eastern Mediterranean. The prevalence in South Africa is not known, but is estimated to be in the range of 0.1-1.7%. 1-3","PeriodicalId":335691,"journal":{"name":"The Southern African Journal of Epidemiology and infection","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Hepatitis C virus infection: an evolving field of medicine\",\"authors\":\"W. Abuelhassan\",\"doi\":\"10.1080/10158782.2012.11441481\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatitis C infection is a leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma. It is also an important indication for liver transplantation in the USA and Europe, yet it is potentially curable. It is estimated that 3% of the world population (170 million people) are infected with hepatitis C. The highest prevalence is in North Africa and the Eastern Mediterranean. The prevalence in South Africa is not known, but is estimated to be in the range of 0.1-1.7%. 1-3\",\"PeriodicalId\":335691,\"journal\":{\"name\":\"The Southern African Journal of Epidemiology and infection\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-07-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Southern African Journal of Epidemiology and infection\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/10158782.2012.11441481\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Southern African Journal of Epidemiology and infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/10158782.2012.11441481","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hepatitis C virus infection: an evolving field of medicine
Hepatitis C infection is a leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma. It is also an important indication for liver transplantation in the USA and Europe, yet it is potentially curable. It is estimated that 3% of the world population (170 million people) are infected with hepatitis C. The highest prevalence is in North Africa and the Eastern Mediterranean. The prevalence in South Africa is not known, but is estimated to be in the range of 0.1-1.7%. 1-3
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
